The FDA’s Center for Tobacco Products, or CTP, is responsible for reviewing these new products, but its process needs reform. According to a report from the Reagan-Udall Foundation, the CTP’s lack of transparency and communication has created significant challenges for companies attempting to navigate the regulatory landscape.

Read more